For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

Anumana Inc., a leader in AI-powered cardiovascular detection algorithms, today announced the appointment of Kevin Ballinger and Jean-Luc Butel to its Board of Directors. In their roles, Ballinger and ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...

AI Nose commercial deployment accelerates in 2026 with dual-engine architecture, industrial expansion, and recurring SaaS revenue modelNew Trusval agreement commits to minimum 600-unit deployment, pos ...

Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...

Augurex CEO Neil Klompas describes why it is difficult for biomarkers to diagnose rheumatoid arthritis in some cases.

Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.

Lentz, a leading expert in female longevity, examine how today’s longevity movement remains fundamentally male-coded, and why ...

Ainos enters 2026 with growing momentum as AI Nose advances from a hardware sensing solution into a foundational AI platform that converts scent into structured, machine-readable data for global ...

(NASDAQ:AIMD)(NASDAQ:AIMDW), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that it has entered into a distribution and deployment ...